Strados Labs specializes in innovative respiratory monitoring solutions, offering the RESP® Biosensor, the first FDA-cleared wearable stethoscope designed to detect coughs and wheezes. This cutting-edge technology enables continuous and accurate monitoring of lung sounds and symptoms, significantly enhancing patient care by providing healthcare professionals with real-time insights into their patients' respiratory health from hospital to home. The device works in conjunction with a mobile app and cloud storage to track and trend lung sound events over time, facilitating improved treatment plans.

Founded to transform the management of lung health, Strados Labs has made significant strides with its award-winning technology, which is clinically validated against leading standards. The company has captured over 600,000 coughs and 19 million breaths across four continents and 35 languages. Their commitment to privacy and security ensures that patient data is securely encrypted, highlighting a design that prioritizes user comfort while collecting vital health information. This combination of features positions Strados Labs as a leader in the respiratory healthcare landscape, making every breath count for patients everywhere.